| NAME |
LOPINAVIR 100MG/RITONAVIR 25MG TAB |
| VA GENERIC NAME |
LOPINAVIR/RITONAVIR |
| DOSAGE FORM |
TAB |
| FDA MED GUIDE |
Lopinavir-Ritonavir_(Kaletra)_(2020).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| FORMULARY DESIGNATOR TEXT |
Restricted to HIV/ID (or facility designated/authorized provider)
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
LOPINAVIR/RITONAVIR TAB |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
- COPAY END DATE: 2021-06-16 00:00:00
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2021-06-17 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
LOPINAVIR 100MG/RITONAVIR 25MG TAB |
| VA PRODUCT IDENTIFIER |
L0422 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4026960 |
| EFFECTIVE DATE/TIME |
-
- 2007-12-20 00:00:00
- STATUS: ACTIVE
|
